• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Europe Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012 Product Image

Europe Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012

  • Published: January 2009
  • Region: Europe
  • 123 pages
  • Global Markets Direct

FEATURED COMPANIES

  • 3M Company
  • B. Braun Melsungen AG
  • Boehringer Ingelheim GmbH
  • Consort Medical plc
  • Novagali Pharma SA
  • SkyePharma PLC
  • MORE

Europe Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012

Summary

This report is an essential source for in-depth information and data relating to Europe drug delivery devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the drug delivery devices in Europe

Scope

- The report provides drug delivery devices information broken down into detailed categories in Europe.
- Total revenues, products sold and end users.
- Market shares of all the key competitors.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers READ MORE >

1 Table Of Contents 2
1.1 List of Tables 9
1.2 List of Figures 12
2 Introduction 14
2.1 What Is This Report About? 14
3 Definitions of the Markets Covered in the Report 15
3.1 Drug delivery devices 15
3.2 Inhalation Systems 15
3.2.1 Metered Dose Inhaler 15
3.2.2 Dry powder inhaler 15
3.3 Infusion Systems 15
3.3.1 Infusion pumps 15
3.3.2 Syringe pumps 16
3.3.3 Disposable Infusion sets 16
3.4 Needle-free Injections 16
4 Drug Delivery Devices in Europe 17
4.1 Drug Delivery Devices Cross Country Comparison (2000-2012) 17
4.2 Drug Delivery Devices, Europe, Overall Revenues ($ mn), 2000-2012 18
4.3 Drug Delivery Devices, Europe, Company Share (2006-2007) 22
5 Drug Delivery Devices In Germany 23
5.1 Drug Delivery Devices, Germany, Overall Revenues ($ mn), 2000-2012 23
5.2 Drug Delivery Devices, Germany, Category Volume (Units), 2000-2012 26
5.3 Drug Delivery Devices, Germany, Distribution Share (2006-2007) 29
5.3.1 Infusion Systems Distribution Share (2006-2007) 29
5.3.2 Inhalation Systems Distribution Share (2006-2007) 29
5.3.3 Needle Free Injections Distribution Share (2006-2007) 30
5.4 Drug Delivery Devices, Germany, Company Share (2006-2007) 31
5.4.1 Drug Delivery Devices, Germany, Company Share (2006-2007) 31
5.4.2 Infusion Systems, Germany, Company Share (2006-2007) 32
5.4.3 Inhalation Systems, Germany, Company Share (2006-2007) 33
6 Drug Delivery Devices In France 34
6.1 Drug Delivery Devices, France, Overall Revenues ($ mn), 2000-2012 34
6.2 Drug Delivery Devices, France, Category Volume (Units), 2000-2012 37
6.3 Drug Delivery Devices, France, Distribution Share (2006-2007) 40
6.3.1 Infusion Systems Distribution Share (2006-2007) 40
6.3.2 Infusion Systems Distribution Share (2006-2007) 40
6.3.3 Needle Free Injections Distribution Share (2006-2007) 41
6.4 Drug Delivery Devices, France, Company Share (2006-2007) 42
6.4.1 Drug Delivery Devices, France, Company Share (2006-2007) 42
6.4.2 Infusion Systems, France, Company Share (2006-2007) 43
6.4.3 Inhalation Systems, France, Company Share (2006-2007) 44
7 Drug Delivery Devices In United Kingdom 45
7.1 Drug Delivery Devices, United Kingdom, Overall Revenues ($ mn), 2000-2012 45
7.2 Drug Delivery Devices, United Kingdom, Category Volume (Units), 2000-2012 48
7.3 Drug Delivery Devices, United Kingdom, Distribution Share (2006-2007) 51
7.3.1 Infusion Systems Distribution Share (2006-2007) 51
7.3.2 Inhalation Systems Distribution Share (2006-2007) 51
7.3.3 Needle Free Injections Distribution Share (2006-2007) 52
7.4 Drug Delivery Devices, United Kingdom, Company Share (2006-2007) 53
7.4.1 Drug Delivery Devices, United Kingdom, Company Share (2006-2007) 53
7.4.2 Infusion Systems, United Kingdom, Company Share (2006-2007) 54
7.4.3 Inhalation Systems, United Kingdom, Company Share (2006-2007) 55
8 Drug Delivery Devices In Italy 56
8.1 Drug Delivery Devices, Italy, Overall Revenues ($ mn), 2000-2012 56
8.2 Drug Delivery Devices, Italy, Category Volume (Units), 2000-2012 59
8.3 Drug Delivery Devices, Italy, Distribution Share (2006-2007) 62
8.3.1 Infusion Systems Distribution Share (2006-2007) 62
8.3.2 Inhalation Systems Distribution Share (2006-2007) 62
8.3.3 Needle Free Injections Distribution Share (2006-2007) 63
8.4 Drug Delivery Devices, Italy, Company Share (2006-2007) 64
8.4.1 Drug Delivery Devices, Italy, Company Share (2006-2007) 64
8.4.2 Infusion Systems, Italy, Company Share (2006-2007) 65
8.4.3 Inhalation Systems, Italy, Company Share (2006-2007) 66
9 Drug Delivery Devices In Spain 67
9.1 Drug Delivery Devices, Spain, Overall Revenues ($ mn), 2000-2012 67
9.2 Drug Delivery Devices, Spain, Category Volume (Units), 2000-2012 70
9.3 Drug Delivery Devices, Spain, Distribution Share (2006-2007) 73
9.3.1 Infusion Systems Distribution Share (2006-2007) 73
9.3.2 Inhalation Systems Distribution Share (2006-2007) 73
9.3.3 Needle Free Injections Distribution Share (2006-2007) 74
9.4 Drug Delivery Devices, Spain, Company Share (2006-2007) 75
9.4.1 Drug Delivery Devices, Spain, Company Share (2006-2007) 75
9.4.2 Infusion Systems, Spain, Company Share (2006-2007) 76
9.4.3 Inhalation Systems, Spain, Company Share (2006-2007) 77
10 AstraZeneca PLC Company Profile 78
10.1 Company Overview 78
11 GlaxoSmithKline plc Company Profile 79
11.1 Company Overview 79
12 Cardinal Health, Inc. Company Profile 80
12.1 Company Overview 80
12.2 Value Chain Analysis 80
12.2.1 Manufacturing 81
12.2.1.1 In House Manufacturing 81
12.2.1.2 Outsourcing 81
12.2.2 Product Development 81
12.2.2.1 Regulatory Approvals 81
12.2.2.2 Research and Development 81
12.2.3 Sales and Marketing 82
12.2.3.1 Partnerships and Alliances 82
12.2.3.2 Licensing Agreements 82
13 3M Company Company Profile 83
13.1 Company Overview 83
13.2 Value Chain Analysis 84
13.2.1 Manufacturing 84
13.2.1.1 In House Manufacturing 84
13.2.2 Product Development 84
13.2.2.1 Regulatory Approvals 84
13.2.2.2 Clinical Trials 84
13.2.2.3 Research and Development 85
13.2.3 Sales and Marketing 85
13.2.3.1 Partnerships and Alliances 85
13.2.3.2 Licensing Agreements 85
13.2.3.3 E-distribution 85
14 Baxter International Inc. Company Profile 86
14.1 Company Overview 86
14.2 Value Chain Analysis 87
14.2.1 Manufacturing 87
14.2.1.1 In House Manufacturing 87
14.2.2 Product Development 87
14.2.2.1 Regulatory Approvals 87
14.2.2.2 Clinical Trials 88
14.2.2.3 Research and Development 88
14.2.3 Sales and Marketing 88
14.2.3.1 Partnerships and Alliances 88
14.2.3.2 Licensing Agreements 88
14.2.3.3 E-distribution 89
14.3 Baxter International Inc. Pipeline Products 89
14.3.1 Baxter International Inc. Pipeline Products By Equipment Type 89
14.3.2 Baxter International Inc. Pipeline Products By Development Stage 89
14.3.3 Baxter International Inc. Pipeline Products By Therapy Area 89
14.3.4 Baxter International Inc. Pipeline Products By Clinical Trials 90
14.3.5 Baxter International Inc. Pipeline Products By News Summary 90
15 Novartis Medical Nutrition Company Profile 91
15.1 Company Overview 91
16 Boehringer Ingelheim GmbH Company Profile 92
16.1 Company Overview 92
16.2 Value Chain Analysis 93
16.2.1 Manufacturing 93
16.2.1.1 In House Manufacturing 93
16.2.1.2 Outsourcing 93
16.2.2 Product Development 94
16.2.2.1 Regulatory Approvals 94
16.2.2.2 Clinical Trials 94
16.2.2.3 Research and Development 94
16.2.3 Sales and Marketing 94
16.2.3.1 Licensing Agreements 94
16.2.3.2 Partnerships and Alliances 94
17 B. Braun Melsungen AG Company Profile 95
17.1 Company Overview 95
17.2 Value Chain Analysis 95
17.2.1 Manufacturing 96
17.2.1.1 In House Manufacturing 96
17.2.1.2 Outsourcing 96
17.2.2 Product Development 96
17.2.2.1 Regulatory Approvals 96
17.2.2.2 Clinical Trials 96
17.2.2.3 Research and Development 97
17.2.3 Sales and Marketing 97
17.2.3.1 Partnerships and Alliances 97
17.2.3.2 Licensing Agreements 97
18 Arcomedical Infusion Limited Company Profile 99
18.1 Company Overview 99
19 Consort Medical plc Company Profile 99
19.1 Company Overview 99
19.2 Value Chain Analysis 100
19.2.1 Manufacturing 100
19.2.1.1 In House Manufacturing 100
19.2.2 Product Development 100
19.2.2.1 Regulatory Approvals 100
19.2.2.2 Clinical Trials 101
19.2.2.3 Research and Development 101
19.2.3 Sales and Marketing 101
19.2.3.1 Partnerships and Alliances 101
19.2.3.2 Licensing Agreements 101
19.3 Consort Medical plc Pipeline Products 102
19.3.1 Consort Medical plc Pipeline Products by Equipment Type 102
19.3.2 Consort Medical plc Pipeline Products By Development Stage 102
19.3.3 Consort Medical plc Pipeline Products By Therapy Area 102
20 Novagali Pharma SA Company Profile 103
20.1 Company Overview 103
21 SEDAT Company Profile 104
21.1 Company Overview 104
22 SkyePharma PLC Company Profile 105
22.1 Company Overview 105
22.2 SkyePharma PLC Pipeline Products 105
22.2.1 SkyePharma PLC Pipeline Products By Equipment Type 105
22.2.2 SkyePharma PLC Pipeline Products By Development Stage 105
22.2.3 SkyePharma PLC Pipeline Products By Therapy Area 105
23 Vectura Group plc Company Profile 106
23.1 Company Overview 106
23.2 Vectura Group plc Pipeline Products 106
23.2.1 Vectura Group plc Pipeline Products by Equipment Type 106
23.2.2 Vectura Group plc Pipeline Products By Development Stage 106
23.2.3 Vectura Group plc Pipeline Products By Therapy Area 107
23.2.4 Vectura Group plc Pipeline Products By Clinical Trials 107
24 Financial Deals Landscape 108
24.1 Acquisition 108
24.2 Partnerships 114
25 Recent Developments 117
25.1 Product News 117
25.1.1 Oct 07, 2008: PARI Pharma Unveils Closed System Using eFlow Technology At Medical Plastics Conference 117
25.1.2 Sep 24, 2008: Bayer HealthCare Pharmaceuticals Launching New Needle For Betaseron 117
26 APPENDIX 118
26.1 Global Markets Direct Research Methodology 118
26.2 Coverage 119
26.3 Secondary Research 119
26.4 Primary Research 120
26.5 Models 120
26.6 Forecasts 121
26.7 Expert Panels 121
26.8 Currency Conversion 122
26.9 Contact Us 123
26.10 Disclaimer 123

Executive Summary

1.2 List of Figures
Figure 1: Drug Delivery Devices, Europe, Cross Country Comparison, Revenues ($ mn), 2000-2012 17
Figure 2: Drug Delivery Devices, Europe, Overall Revenues ($ mn), 2000-2012 18
Figure 3: Drug Delivery Devices, Europe, Portfolio Analysis, 2000-2012 19
Figure 4: Drug Delivery Devices, Europe, Overall Revenues ($ mn), Historic, 2000-2007 20
Figure 5: Drug Delivery Devices, Europe, Overall Revenues ($ mn), Forecast, 2007-2012 21
Figure 6: Drug Delivery Devices, Europe, Company Share (%), 2007 22
Figure 7: Drug Delivery Devices, Germany, Overall Revenues ($ mn), 2000-2012 23
Figure 8: Drug Delivery Devices, Germany, Overall Revenues ($ mn), Historic, 2000-2007 24
Figure 9: Drug Delivery Devices, Germany, Overall Revenues ($ mn), Forecast, 2007-2012 25
Figure 10: Drug Delivery Devices, Germany, Category Volume (Units), 2000-2012 26
Figure 11: Drug Delivery Devices, Germany, Category Volume (Units), Historic, 2000-2007 27
Figure 12: Drug Delivery Devices, Germany, Category Volume (Units), Forecast, 2007-2012 28
Figure 13: Drug Delivery Devices, Germany, Company Share (%), 2007 31
Figure 14: Infusion Systems, Germany, Company Share (%), 2007 32
Figure 15: Inhalation Systems, Germany, Company Share (%), 2007 33
Figure 16: Drug Delivery Devices, France, Overall Revenues ($ mn), 2000-2012 34
Figure 17: Drug Delivery Devices, France, Overall Revenues ($ mn), Historic, 2000-2007 35
Figure 18: Drug Delivery Devices, France, Overall Revenues ($ mn), Forecast, 2007-2012 36
Figure 19: Drug Delivery Devices, France, Category Volume (Units), 2000-2012 37
Figure 20: Drug Delivery Devices, France, Category Volume (Units), Historic, 2000-2007 38
Figure 21: Drug Delivery Devices, France, Category Volume (Units), Forecast, 2007-2012 39
Figure 22: Drug Delivery Devices, France, Company Share (%), 2007 42
Figure 23: Infusion Systems, France, Company Share (%), 2007 43
Figure 24: Inhalation Systems, France, Company Share (%), 2007 44
Figure 25: Drug Delivery Devices, United Kingdom, Overall Revenues ($ mn), 2000-2012 45
Figure 26: Drug Delivery Devices, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007 46
Figure 27: Drug Delivery Devices, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012 47
Figure 28: Drug Delivery Devices, United Kingdom, Category Volume (Units), 2000-2012 48
Figure 29: Drug Delivery Devices, United Kingdom, Category Volume (Units), Historic, 2000-2007 49
Figure 30: Drug Delivery Devices, United Kingdom, Category Volume (Units), Forecast, 2007-2012 50
Figure 31: Drug Delivery Devices, United Kingdom, Company Share (%), 2007 53
Figure 32: Infusion Systems, United Kingdom, Company Share (%), 2007 54
Figure 33: Inhalation Systems, United Kingdom, Company Share (%), 2007 55
Figure 34: Drug Delivery Devices, Italy, Overall Revenues ($ mn), 2000-2012 56
Figure 35: Drug Delivery Devices, Italy, Overall Revenues ($ mn), Historic, 2000-2007 57
Figure 36: Drug Delivery Devices, Italy, Overall Revenues ($ mn), Forecast, 2007-2012 58
Figure 37: Drug Delivery Devices, Italy, Category Volume (Units), 2000-2012 59
Figure 38: Drug Delivery Devices, Italy, Category Volume (Units), Historic, 2000-2007 60
Figure 39: Drug Delivery Devices, Italy, Category Volume (Units), Forecast, 2007-2012 61
Figure 40: Drug Delivery Devices, Italy, Company Share (%), 2007 64
Figure 41: Infusion Systems, Italy, Company Share (%), 2007 65
Figure 42: Inhalation Systems, Italy, Company Share (%), 2007 66
Figure 43: Drug Delivery Devices, Spain, Overall Revenues ($ mn), 2000-2012 67
Figure 44: Drug Delivery Devices, Spain, Overall Revenues ($ mn), Historic, 2000-2007 68
Figure 45: Drug Delivery Devices, Spain, Overall Revenues ($ mn), Forecast, 2007-2012 69
Figure 46: Drug Delivery Devices, Spain, Category Volume (Units), 2000-2012 70
Figure 47: Drug Delivery Devices, Spain, Category Volume (Units), Historic, 2000-2007 71
Figure 48: Drug Delivery Devices, Spain, Category Volume (Units), Forecast, 2007-2012 72
Figure 49: Drug Delivery Devices, Spain, Company Share (%), 2007 75
Figure 50: Infusion Systems, Spain, Company Share (%), 2007 76
Figure 51: Inhalation Systems, Spain, Company Share (%), 2007 77
Figure 52: Cardinal Health, Inc. Value Chain Analysis 80
Figure 53: 3M Healthcare Value Chain Analysis 84
Figure 54: Baxter International Inc. Value Chain Analysis 87
Figure 55: Boehringer Ingelheim GmbH Value Chain Analysis 93
Figure 56: B. Braun Melsungen AG Value Chain Analysis 95
Figure 57: Consort Medical plc Value Chain Analysis 100
Figure 58: Global Markets Direct Methodology 118

AstraZeneca PLC
GlaxoSmithKline plc
Cardinal Health, Inc.
3M Company
Baxter International Inc.
Novartis Medical Nutrition
Boehringer Ingelheim GmbH
B. Braun Melsungen AG
Arcomedical Infusion Limited
Consort Medical plc
Novagali Pharma SA
SEDAT
SkyePharma PLC
Vectura Group plc

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos